Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RARB | P10826 | 8/20 | 0.78 |
| ▸ | PPARA | Q07869 | 2/20 | 0.72 |
| ▸ | KAT8 | Q9H7Z6 | 2/20 | 0.68 |
| ▸ | PPARG | P37231 | 1/20 | 0.67 |
| ▸ | RARA | P10276 | 2/20 | 0.61 |
| ▸ | RARG | P13631 | 1/20 | 0.61 |
| ▸ | PLK1 | P53350 | 6/20 | 0.59 |
| ▸ | PLK3 | Q9H4B4 | 1/20 | 0.59 |
| ▸ | MEN1 | O00255 | 1/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.58 |
| ▸ | MAPT | P10636 | 1/20 | 0.58 |
| ▸ | MTOR | P42345 | 1/20 | 0.58 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11028587 | 1.00 | RARB (0.78) | RARBPPARAKAT8PPARGRARA | |
| SCHEMBL4308582 | 1.00 | RARB (0.78) | RARBPPARAKAT8PPARGRARA | |
| SCHEMBL20503376 | 1.00 | RARB (0.78) | RARBPPARAKAT8PPARGRARA | |
| SCHEMBL551744 | 0.93 | RARB (0.68) | RARBPPARAKAT8PPARGRARA | |
| SCHEMBL4187659 | 0.88 | RARB (1.00) | RARBPPARAKAT8PPARGRARA | |
| SCHEMBL4611393 | 0.88 | RARB (1.00) | RARBPPARAKAT8PPARGRARA | |
| SCHEMBL3033031 | 0.87 | KAT8 (0.77) | RARBPPARAKAT8PPARGRARA | |
| SCHEMBL10792437 | 0.87 | KAT8 (0.77) | RARBPPARAKAT8PPARGRARA | |
| SCHEMBL9665751 | 0.87 | KAT8 (0.77) | RARBPPARAKAT8PPARGRARA | |
| SCHEMBL3029363 | 0.87 | KAT8 (0.77) | RARBPPARAKAT8PPARGRARA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3377473-B1 | MACROCYCLIC BROAD SPECTRUM ANTIBIOTICS | RQX PHARMACEUTICALS INC (US) | 2024-06-19 | — | — | EP | disclosed |
| US-20230133817-A1 | MACROCYCLIC BROAD SPECTRUM ANTIBIOTICS | RQX PHARMACEUTICALS INC (US) | 2023-05-04 | — | — | US | disclosed |
| US-20230133817-A1 | MACROCYCLIC BROAD SPECTRUM ANTIBIOTICS | RQX PHARMACEUTICALS INC (US) | 2023-05-04 | — | — | US | disclosed |
| CN-107526256-B | Toner compositions with anti-plasticizers | 施乐公司 | 2023-04-07 | — | — | CN | disclosed |
| CN-108884058-B | Macrocyclic broad spectrum antibiotics | 阿奇克斯制药公司 | 2022-04-29 | — | — | CN | disclosed |
| CN-108884058-A | MACROCYCLIC BROAD SPECTRUM ANTIBIOTICS | 阿奇克斯制药公司 | 2018-11-23 | — | — | CN | disclosed |
| US-20180327367-A1 | MACROCYCLIC BROAD SPECTRUM ANTIBIOTICS | WUXI APPTEC CO., LTD (CN) | 2018-11-15 | — | — | US | disclosed |
| EP-3377473-A1 | MACROCYCLIC BROAD SPECTRUM ANTIBIOTICS | RQX Pharmaceuticals, Inc. (US) | 2018-09-26 | — | — | EP | disclosed |
| EP-2555273-B1 | ORGANIC ELECTRIC-FIELD LIGHT-EMITTING DEVICE MATERIAL, ORGANIC ELECTRIC-FIELD LIGHT-EMITTING DEVICE FORMED OF SAME, AND METHOD FOR MANUFACTURING ORGANIC ELECTRIC-FIELD LIGHT-EMITTING DEVICE | UDC IRELAND LTD (IE) | 2017-09-27 | — | — | EP | disclosed |
| US-9601705-B2 | Material for organic electroluminescence element and organic electroluminescence element using the same, and method for manufacturing organic electroluminescence element | UDC IRELAND LIMITED (IE) | 2017-03-21 | — | — | US | disclosed |
| EP-1354887-B1 | Ligands for metals and improved metal-catalyzed processes based thereon | MASSACHUSETTS INST TECHNOLOGY (US) | 2007-04-25 | — | — | EP | disclosed |
| US-7067230-B2 | Photorefractive composite | NITTO DENKO CORPORATION (JP) | 2006-06-27 | — | — | US | disclosed |
| EP-1097158-B1 | LIGANDS FOR METALS AND METAL-CATALYZED PROCESSES | MASSACHUSETTS INST TECHNOLOGY (US) | 2006-01-25 | — | — | EP | disclosed |
| US-20050209478-A1 | Polydioxaborines | ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA | 2005-09-22 | — | — | US | disclosed |
| US-6916894-B2 | Polydioxaborines | NITTO DENKO CORPORATION (JP) | 2005-07-12 | — | — | US | disclosed |
| EP-1490377-A1 | POLYDIOXABORINES, THEIR MONOMERS AND THEIR PREPARATION | Nitto Denko Corporation (JP) | 2004-12-29 | — | — | EP | disclosed |
| US-20040200999-A1 | Photorefractive composite | NITTO DENKO CORPORATION (JP) | 2004-10-14 | — | — | US | disclosed |
| US-20030220500-A1 | An acrylic ester polymers comprise a 1,3,2- dioxaborine group in the side chain; soluble, film formers, and have semiconducting properties | NITTO DENKO CORPORATION (JP) | 2003-11-27 | — | — | US | disclosed |
| EP-1354887-A1 | Ligands for metals and improved metal-catalyzed processes based thereon | Massachusetts Insitute of Technology (US) | 2003-10-22 | — | — | EP | disclosed |
| WO-2003084968-A1 | POLYDIOXABORINES, THEIR MONOMERS AND THEIR PREPARATION | NITTO DENKO CORPORATION (JP) | 2003-10-16 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050209478-A1 | Polydioxaborines | DAXX, PUF60, DCAF7 | RARB 1519/4885PPARA 3941/4885KAT8 4607/4885 |
| US-20180327367-A1 | MACROCYCLIC BROAD SPECTRUM ANTIBIOTICS | MRPL21, PEPD, CTSC | RARB 1554/4885PPARA 3021/4885KAT8 4090/4885 |
| US-20230133817-A1 | MACROCYCLIC BROAD SPECTRUM ANTIBIOTICS | MRPL21, PEPD, CTSC | RARB 1554/4885PPARA 3021/4885KAT8 4090/4885 |
| US-20030220500-A1 | An acrylic ester polymers comprise a 1,3,2- dioxaborine group in the side chain; soluble, film formers, and have semiconducting properties | DAXX, CAD, PUF60 | RARB 1101/4885PPARA 3060/4885KAT8 4030/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.